tiprankstipranks
Q32 Bio (QTTB)
NASDAQ:QTTB
Holding QTTB?
Track your performance easily

Q32 Bio (QTTB) Income Statement

800 Followers

Q32 Bio Income Statement

Last quarter (Q3 2024), Q32 Bio's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Q32 Bio's net income was $-17.59M. See Q32 Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ -2.15M$ 1.16M$ 6.65M$ 33.97M$ 2.70M$ 1.67M
Cost of Revenue
------
Gross Profit
-$ 1.16M$ 3.21M$ 33.97M$ 2.70M$ 1.67M
Operating Expense
$ 63.68M$ 102.58M$ 45.88M$ 129.92M$ 132.97M$ 111.61M
Operating Income
$ -63.65M$ -101.40M$ -133.28M$ -95.95M$ -130.26M$ -109.94M
Net Non Operating Interest Income Expense
------
Other Income Expense
$ -13.77M$ -14.35M$ -3.52M$ -185.00K$ -1.57M$ -6.03M
Pretax Income
$ -53.28M$ -87.08M$ -42.75M$ -95.76M$ -128.69M$ -103.92M
Tax Provision
$ -8.50M$ -8.50M$ 62.00K$ -8.24M--
Earnings From Equity Interest Net Of Tax
$ -1.63M-----
Net Income Common Stockholders
$ -89.21M$ -112.96M$ -42.81M$ -95.76M$ -128.69M$ -103.92M
Basic EPS
$ -1.20$ -1.95$ -1.62$ -31.14$ -2.80-
Diluted EPS
$ -8.56$ -1.95$ -1.62$ -31.14$ -2.80$ -2.47
Basic Average Shares
$ 83.01M$ 57.83M$ 3.19M$ 3.07M$ 45.91M$ 42.12M
Diluted Average Shares
$ 84.35M$ 57.83M$ 3.19M$ 3.07M$ 45.91M$ 42.12M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 63.68M$ 102.58M$ 45.88M$ 129.92M$ 132.97M$ 111.61M
Net Income From Continuing And Discontinued Operation
$ -71.70M$ -112.96M$ -42.81M$ -95.76M$ -128.69M$ -103.92M
Normalized Income
$ -32.05M$ -85.80M-$ -104.10M--
Interest Expense
------
EBIT
$ -57.06M$ -87.08M$ -39.23M$ -95.76M$ -128.69M$ -103.92M
EBITDA
$ -47.62M$ -89.45M$ -38.85M$ -88.31M$ -120.93M$ -97.60M
Currency in USD

Q32 Bio Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis